| Title |
A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr)
|
|---|---|
| Published in |
Cancer Immunology, Immunotherapy, December 2004
|
| DOI | 10.1007/s00262-004-0616-7 |
| Pubmed ID | |
| Authors |
Ralf G. Meyer, Cedrik M. Britten, Ulrike Siepmann, Barbara Petzold, Tolga A. Sagban, Hans A. Lehr, Bernd Weigle, Marc Schmitz, Luis Mateo, Burkhard Schmidt, Helga Bernhard, Thilo Jakob, Rüdiger Hein, Gerold Schuler, Beatrice Schuler-Thurner, Stephan N. Wagner, Ingo Drexler, Gerd Sutter, Nathaly Arndtz, Paul Chaplin, Jost Metz, Alexander Enk, Christoph Huber, Thomas Wölfel |
Mendeley readers
The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Denmark | 2 | 5% |
| Malaysia | 1 | 2% |
| South Africa | 1 | 2% |
| Unknown | 37 | 90% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 7 | 17% |
| Student > Ph. D. Student | 7 | 17% |
| Student > Master | 6 | 15% |
| Student > Doctoral Student | 4 | 10% |
| Other | 3 | 7% |
| Other | 7 | 17% |
| Unknown | 7 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 15 | 37% |
| Medicine and Dentistry | 7 | 17% |
| Immunology and Microbiology | 5 | 12% |
| Biochemistry, Genetics and Molecular Biology | 4 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 2% |
| Other | 2 | 5% |
| Unknown | 7 | 17% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 May 2020.
All research outputs
#4,759,175
of 23,031,582 outputs
Outputs from Cancer Immunology, Immunotherapy
#506
of 2,895 outputs
Outputs of similar age
#16,954
of 140,034 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#11
of 23 outputs
Altmetric has tracked 23,031,582 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,895 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 140,034 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.